No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, Dantanarayana A, Wightman F, Hagenauer M, Roney J, Spelman T, Purcell DF, McMahon J, Hoy JF, Prince HM, Elliott JH, Lewin SR
HIV + AIDS
Multidetector (64+) Computed Tomography Angiography of the Lower Limb in Symptomatic Peripheral Arterial Disease: Assessment of Image Quality and Accuracy in a Tertiary Care Setting.
Lim JC, Ranatunga D, Owen A, Spelman T, Galea M, Chuen J, Lim RP
Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
Yong YK, Shankar EM, Westhorpe CLV, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR
Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay.
Yong MK, Cameron PU, Spelman T, Elliott JH, Fairley CK, Boyle J, Miyamasu M, Lewin SR
Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH, Spelman T, Ford N, Greig J, Mesic A, Ssonko C, Casas EC, O'Brien DP
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME, ATAHC Study Group